Speaking of the choir, lets also note the fat lady has not yet sung.
Time to think out side the box folks.
If this was dead, study data wise, why didn't the DSMB already kill it the last 2 years?
Why did the FDA ask for the rest the of the data?
If there was an issue with the first 210, this would have been killed long ago or 1-2 weeks ago by the FDA.
Instead they asked for the rest of the data, before deciding on an end point change request.
Also, the market is not paying attention to biotechs right now...or covid19 stocks.
But you can be damn well sure if the Hospitals are puking patients again into morgues at more than 300/day (which already is still nuts...) and we already know the mothers are going to be going ape on social media about what Covid is doing their kids going forward (News is already showing up), that Approval in the middle of Winter with Covid on another rampage is going to blow this stock up to 100 bagger level gains....
Just ignore the bargain shopping noise...
News 
Market Data 
Discover 
AI
